Fusobacterium nucleatum promotes the development of acute liver failure by inhibiting the NAD+ salvage metabolic pathway

ConclusionsFusobacterium nucleatum coordinates a molecular network including NAD+ and SIRT1 to control the progress of ALF. Detection and targeting ofF. nucleatum and its related pathways may provide valuable insights for the treatment of ALF.

Source: Gut Pathogens - June 28, 2022 Category: Microbiology Source Type: research